Cancer epidemiology in the elderly
- PMID: 11500263
- DOI: 10.1016/s1040-8428(01)00102-0
Cancer epidemiology in the elderly
Abstract
Although age per se is not an important determinant of cancer risk, but rather a surrogate of prolonged carcinogen exposure, the increased life expectancy over the last few decades in most areas of the world has greatly increased cancer burden in the elderly. Trends in mortality for most common cancer sites in the elderly tended systematically to increase up to the early 1990s, but declined thereafter in North America and Western Europe in both sexes, and in Japanese females. Most trends remain unfavourable for elderly population of both sexes in eastern Europe, mainly reflecting patterns in smoking. Trends of incidence in elderly populations are more difficult to interpret, on account of changed diagnosis and certification for several cancer sites, including prostate cancer, brain tumours and multiple myeloma. Screening and early diagnosis for cancer in the elderly should be critically considered for prostate, but also for colorectal, breast and other selected neoplasms.
Similar articles
-
Changed trends of cancer mortality in the elderly.Ann Oncol. 2001 Oct;12(10):1467-77. doi: 10.1023/a:1012539213643. Ann Oncol. 2001. PMID: 11762821
-
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Epidemiol Prev. 2016. PMID: 26951748
-
Worldwide trends in cancer mortality in the elderly, 1955-1992.Eur J Cancer. 1996 Apr;32A(4):652-72. doi: 10.1016/0959-8049(95)00582-x. Eur J Cancer. 1996. PMID: 8695271
-
Common cancers in the elderly.Drugs Aging. 1998 Dec;13(6):467-78. doi: 10.2165/00002512-199813060-00005. Drugs Aging. 1998. PMID: 9883401 Review.
-
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. doi: 10.1093/jnci/djg040. J Natl Cancer Inst. 2003. PMID: 12953083 Review.
Cited by
-
Stage II colorectal cancer: lack of prognostic model.Libyan J Med. 2007 Mar 1;2(1):19-20. doi: 10.4176/061221. Libyan J Med. 2007. PMID: 21503225 Free PMC article. No abstract available.
-
Caloric restriction maintains OX40 agonist-mediated tumor immunity and CD4 T cell priming during aging.Cancer Immunol Immunother. 2014 Jun;63(6):615-26. doi: 10.1007/s00262-014-1542-y. Epub 2014 Mar 30. Cancer Immunol Immunother. 2014. PMID: 24682539 Free PMC article.
-
Do we protect or discriminate? Representation of senior adults in clinical trials.Rep Pract Oncol Radiother. 2012 Sep 26;18(1):6-10. doi: 10.1016/j.rpor.2012.08.006. eCollection 2012. Rep Pract Oncol Radiother. 2012. PMID: 24381741 Free PMC article.
-
Lack of effect of human c-Ha-ras proto-oncogene overexpression on prostate carcinogenesis in probasin/SV40 T antigen transgenic rats.Cancer Sci. 2003 Dec;94(12):1042-5. doi: 10.1111/j.1349-7006.2003.tb01398.x. Cancer Sci. 2003. PMID: 14662018 Free PMC article.
-
Cancer time trend in a population following a socio-economic transition: results of age-period-cohort analysis.Int J Public Health. 2017 Apr;62(3):407-414. doi: 10.1007/s00038-017-0946-9. Epub 2017 Feb 23. Int J Public Health. 2017. PMID: 28233018
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources